$ATRS ANTARES PHARMA, INC. Insider Trading Week 23/2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ANTARES PHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ANTARES PHARMA, INC. in week 23/2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 13 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.77 | 100,000 | 277,000 | 10,286,413 | 10.4 M to 10.3 M (-0.96 %) |
Jun 13 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Sell | S | 2.69 | 100,000 | 269,000 | 10,386,413 | 10.5 M to 10.4 M (-0.95 %) |
Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | SAMSON MARVIN | Director | Option Exercise | A | 2.70 | 76,548 | 206,680 | 76,548 | |
Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | ROCHE ROBERT P JR | Director | Option Exercise | A | 2.70 | 76,548 | 206,680 | 76,548 | |
Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Option Exercise | A | 2.70 | 153,097 | 413,362 | 153,097 | |
Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | GUETH ANTON | Director | Option Exercise | A | 2.70 | 76,548 | 206,680 | 76,548 | |
Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | A | 2.70 | 76,548 | 206,680 | 76,548 | |
Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | A | 2.70 | 76,548 | 206,680 | 76,548 | |
Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | EVP General Counsel ... | Option Exercise | A | 2.70 | 177,453 | 479,123 | 177,453 | |
Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | EVP General Counsel ... | Grant | A | 2.70 | 91,667 | 247,501 | 289,173 | 197.5 K to 289.2 K (+46.41 %) |
Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | EVP General Counsel ... | Payment of Exercise | F | 2.70 | 12,923 | 34,892 | 197,506 | 210.4 K to 197.5 K (-6.14 %) |
Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | Powell Fred M | Executive Vice Pres ... | Option Exercise | A | 2.70 | 177,453 | 479,123 | 177,453 | |
Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | Powell Fred M | Executive Vice Pres ... | Grant | A | 2.70 | 91,667 | 247,501 | 413,492 | 321.8 K to 413.5 K (+28.48 %) |
Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | Powell Fred M | Executive Vice Pres ... | Payment of Exercise | F | 2.70 | 9,609 | 25,944 | 321,825 | 331.4 K to 321.8 K (-2.90 %) |
Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | A | 2.70 | 591,510 | 1,597,077 | 591,510 | |
Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Grant | A | 2.70 | 305,556 | 825,001 | 1,530,562 | 1.2 M to 1.5 M (+24.94 %) |
Jun 11 2018 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Payment of Exercise | F | 2.70 | 32,031 | 86,484 | 1,225,006 | 1.3 M to 1.2 M (-2.55 %) |